Matthew Campbell, MD

Associate Professor
MDA, United States

Disclosure information not submitted.

Presentation(s):

• 338 - Phase I Trial of Cryoablation and Immunotherapy in Patients with Adaptive Immunotherapy Resistance, the CEDAR Trial: Cryoablation Challenge Evaluated in Adaptive-Immune Resistance

  Wednesday, April 15, 2026
  11:42 AM - 11:51 AM ET